Argyle integrates with Tidalwave to deliver embedded, real-time verification of income and employment
NEW YORK CITY, N.Y., May 8, 2025 (SEND2PRESS NEWSWIRE) — Argyle, a service provider automating income and employment verifications for some of the largest lenders in the United States, today announced its integration with Tidalwave, an agentic AI mortgage point-of-sale (POS) platform. The integration embeds Argyle's verification of income and employment (VOIE) solution directly into Tidalwave's borrower workflow, eliminating manual steps and accelerating loan origination as lenders prepare for a more active housing market.
Through this integration, borrowers can connect their payroll provider and verify income and employment data within Tidalwave's Form 1003 application process, removing the need for separate emails or external verification steps. Loan officers can view verification status in real time and request VOIE at any stage of the loan lifecycle, whether at application or later in the process based on lender preferences.
KEY INTEGRATION BENEFITS:
'Lenders no longer have to choose between borrower convenience and quality verification data; the integration between Tidalwave and Argyle delivers both,' said John Hardesty, vice president of mortgage at Argyle. 'By embedding verification at the point of sale, we help lenders move loans through the process faster while ensuring income and employment data remains accurate and complete.'
'Tidalwave leverages agentic AI to keep borrowers engaged while streamlining workflows for lenders,' said Tidalwave Co-founder and CEO Diane Yu. 'By integrating Argyle's verification solution, we reinforce our dedication to delivering an AI-driven mortgage experience that is smarter, faster and more intuitive.'
'At GNB Mortgage, we're always looking for ways to streamline our processes and better serve our customers. This integration is a testament to what's possible when technology providers work together—it gives us timely, reliable data that supports faster, more informed lending decisions,' said Paige Hagerhorst, SVP of operations and technology at GNB Mortgage.
Tidalwave supports a range of loan origination systems, including Encompass® from ICE Mortgage Technology ®, MeridianLink and Calyx, ensuring seamless data interoperability. The Argyle integration is available now to mutual customers, including Great Northern Bank, with expanded availability expected in the coming months.
About Argyle:
Argyle is the leading provider of direct-source, consumer-permissioned income and employment verifications, making it fast and easy to gain secure and reliable access to the most complete real-time datasets stored in consumers' payroll accounts. With Argyle, lenders automate verification workflows to save time, reduce fraud and compliance risks, lower costs, and build better product experiences. As an authorized report supplier for Fannie Mae's Desktop Underwriter® validation service and an approved service provider supporting Freddie Mac's Loan Product Advisor® asset and income modeler (AIM), Argyle empowers mortgage lenders to auto-retrieve paystubs and W-2s, understand consumers' ability to pay and improve loan quality—all at 60–80% less cost. Argyle's commitment to innovation is backed by investors including Bain Capital Ventures, SignalFire, Checkr and Rockefeller Asset Management. For more information on Argyle's industry-leading VOIE platform, visit https://argyle.com/.
About TidalWave:
TidalWave is an agentic AI mortgage POS+ startup that streamlines loan origination through automation and generative AI. TidalWave's platform integrates directly with Fannie Mae's Desktop Underwriter and Freddie Mac's Loan Product Advisor systems, enabling real-time underwriting decisions and reducing manual processes for lenders and borrowers.
Tags: @withArgyle @tidalwave_ai #mortgage #lending
NEWS SOURCE: Argyle
###
MEDIA ONLY CONTACT:
(not for publication online or in print)
Leslie W. Colley
Depth for Argyle
[email protected]
(678) 622-6229
###
Keywords: Mortgage, loan origination systems, Argyle,, AI mortgage point-of-sale, verification of income and employment, NEW YORK CITY, N.Y.
This press release was issued on behalf of the news source (Argyle) who is solely responsibile for its accuracy, by Send2Press® Newswire. Information is believed accurate but not guaranteed. Story ID: S2P126059 APNF0325A
To view the original version, visit: https://www.send2press.com/wire/argyle-integrates-with-tidalwave-to-deliver-embedded-real-time-verification-of-income-and-employment/
© 2025 Send2Press® Newswire, a press release distribution service, Calif., USA.
RIGHTS GRANTED FOR REPRODUCTION IN WHOLE OR IN PART BY ANY LEGITIMATE MEDIA OUTLET - SUCH AS NEWSPAPER, BROADCAST OR TRADE PERIODICAL. MAY NOT BE USED ON ANY NON-MEDIA WEBSITE PROMOTING PR OR MARKETING SERVICES OR CONTENT DEVELOPMENT.
Disclaimer: This press release content was not created by nor issued by the Associated Press (AP). Content below is unrelated to this news story.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Business Wire
2 hours ago
- Business Wire
Zluri Recognized as a Leader in 2025 Gartner® Magic Quadrant™ for SaaS Management Platforms for Second Consecutive Year
MILPITAS, Calif.--(BUSINESS WIRE)--Zluri, the next-generation Identity Governance and Administration platform, today announced its recognition as a Leader in the 2025 Gartner® Magic Quadrant™ for SaaS Management Platforms for the second consecutive year. Zluri was recognized for its Completeness of Vision and Ability to Execute. 'We're honored that Gartner has recognized Zluri again as a Leader,' said Ritish Reddy, CEO and Co-founder of Zluri. "I feel this recognition reinforces our commitment to enabling IT and security teams to achieve complete visibility, control, and governance, all from a single, unified platform." Ritish Reddy further noted, 'We're in the early days of a generational shift — much like the onset of industrialization — where the explosion of SaaS, AI tools, and non-human actors is redefining how work gets done. Organizations are no longer just managing sanctioned apps; they're contending with a sprawl of Shadow IT, Shadow AI, and countless interactions between human and machine identities. This evolving complexity demands a new approach — one that starts with deep application visibility and control, and lays the foundation for stronger, identity-centric governance. Gartner's continued recognition signals that Zluri is trusted and proven in helping enterprises regain control in this new era.' Zluri's patented discovery engine and unified data fabric provides complete visibility into all identities—human and machine—and their interactions across cloud, SaaS, and AI applications, enabling organizations to shift from assumption-based governance to intelligence-driven, activity-based access management. Zluri empowers organizations to proactively detect Shadow IT and monitor GenAI application usage. It streamlines the entire joiner-mover-leaver lifecycle with automated workflows, enhances productivity through self-service access requests, and automates access reviews to ensure ongoing compliance. A complimentary copy of the report is available here. Gartner, Magic Quadrant for SaaS Management Platforms, By Tom Cipolla, Dan Wilson, Lina Al Dana, 30th July 2025. GARTNER is a registered trademark and service mark of Gartner, Inc. and/or its affiliates in the U.S. and internationally, MAGIC QUADRANT is a registered trademark of Gartner, Inc. and/or its affiliates and is used herein with permission. All rights reserved. Gartner does not endorse any vendor, product, or service depicted in its research publications and does not advise technology users to select only those vendors with the highest ratings or other designation. Gartner research publications consist of the opinions of Gartner's research organization and should not be construed as statements of fact. Gartner disclaims all warranties, expressed or implied, with respect to this research, including any warranties of merchantability or fitness for a particular purpose. About Zluri Zluri is a next-gen Identity Governance and Administration (IGA) platform that enables IT and security teams to discover identities and applications, streamline access management, and automate access reviews—all from a single, intuitive interface. For more information, visit
Business Wire
2 hours ago
- Business Wire
Brazilian Firms Add Resilience with Cybersecurity Advances
SíO PAULO--(BUSINESS WIRE)--Enterprises in Brazil are increasing investments in cybersecurity as both attacks and defensive technologies grow more sophisticated, according to a new research report published today by Information Services Group (ISG) (Nasdaq: III), a global AI-centered technology research and advisory firm. Cybersecurity is crucial for business resilience and growth. Brazilian companies are transforming their security strategies for evolving technology and regulation, often with the help of service providers. The 2025 ISG Provider Lens ® Cybersecurity — Services and Solutions report for Brazil finds growing concern about the cost of data breaches in terms of downtime, damage to brand reputation and potential fines and lawsuits. In Brazil, costs have risen with the increasing complexity of responding to incidents, especially for companies with a shortage of skilled labor. Enterprises also face the growing challenge of complying with the country's General Data Protection Law (LGPD), which sets strict requirements for collecting, storing, processing and sharing personal data. 'Cybersecurity is crucial for business resilience and growth,' said Doug Saylors, partner and leader of ISG Cybersecurity. 'Brazilian companies are transforming their security strategies for evolving technology and regulation, often with the help of service providers.' Enterprises in Brazil are increasingly using AI to strengthen their defenses, while AI adoption also presents new challenges in areas such as privacy, the report says. Cybersecurity systems enhanced with AI and ML allow companies to analyze large volumes of security data, including system logs, network alerts and threat intelligence information, in real time. They can accelerate malware detection, automate incident response and orchestrate actions among security tools. By reducing false positives, AI can free overburdened security teams to focus on real threats. Brazilian companies are also beginning to adopt zero trust architecture, which requires continual verification of users even within an enterprise's network, ISG says. This architecture is quickly becoming a de facto standard, but many Brazilian companies need to modernize their systems to implement the essential tools of zero trust, such as identity and access management (IAM). Brazil is activating collaboration among enterprises, suppliers, government agencies and academic institutions to strengthen its national cybersecurity posture, ISG says. Several initiatives, including the National Cybersecurity Strategy (E-Ciber), established in 2020, facilitate threat information sharing and coordinate incident responses among the public sector and those managing critical infrastructure. The global shortage of cybersecurity talent is especially acute in Brazil, with an estimated shortfall of 750,000 qualified information security professionals, the report says. To fill essential roles in areas such as cloud security and incident response, many firms are turning to service providers. 'Hybrid cloud and multicloud IT environments increase the complexity of cybersecurity, while the growing use of AI is creating new challenges for data protection,' said João Mauro, lead analyst, ISG Provider Lens Research, and lead author of the report. 'Providers can mitigate the need to constantly attract and retain specialized security staff.' The report also explores other cybersecurity trends affecting enterprises in Brazil, including the growing importance of security service edge (SSE) solutions, and surveys the market for extended detection and response (XDR) both globally and in Brazil. For more insights into the cybersecurity challenges facing Brazilian enterprises, plus ISG's advice for overcoming them, see the ISG Provider Lens ® Focal Points briefing here. The 2025 ISG Provider Lens ® Cybersecurity — Services and Solutions report for Brazil evaluates the capabilities of 113 providers across nine quadrants: Identity and Access Management (Global), Extended Detection and Response (Global), Extended Detection and Response (Brazil), Security Service Edge (Global), Technical Security Services, Strategic Security Services, Next-Gen SOC/MDR Services — Large Accounts, Next-Gen SOC/MDR Services — Midmarket and Risk-based Vulnerability Management. The report names IBM as a Leader in six quadrants and ISH Tecnologia as a Leader in five quadrants. It names Accenture, EY, Logicalis and Stefanini as Leaders in four quadrants each. Broadcom, Capgemini, Microsoft and NTT DATA are named as Leaders in three quadrants each. Agility, CrowdStrike, Deloitte, Edge UOL, Fortinet, Palo Alto Networks and Trend Micro are named as Leaders in two quadrants each. Cato Networks, Check Point Software, Cipher, Cisco, CyberArk, Forcepoint, Kaspersky, KPMG, Kyndryl, ManageEngine, Netskope, Okta, One Identity (OneLogin), Ping Identity, PwC, SailPoint, Saviynt, SEK, SentinelOne, TIVIT, Trellix, Unisys, Versa Networks, Vultus, YSSY and Zscaler are named as Leaders in one quadrant each. In addition, Asper, BeyondTrust, Cloud Target, Deloitte, FUTURE TECHNOLOGIES, HPE (Aruba), Italtel, Kyndryl, Pride Security and Sophos are named as Rising Stars — companies with a 'promising portfolio' and 'high future potential' by ISG's definition — in one quadrant each. Customized versions of the report are available from Kaspersky, ISH Tecnologia, Scunna, Vortex Security and Vultus. In the area of customer experience, PwC is named the global ISG CX Star Performer for 2025 among cybersecurity service and solution providers. PwC earned the highest customer satisfaction scores in ISG's Voice of the Customer survey, which is part of the ISG Star of Excellence™ program, the premier quality recognition for the technology and business services industry. The 2025 ISG Provider Lens ® Cybersecurity — Services and Solutions report for Brazil is available to subscribers or for one-time purchase on this webpage. About ISG Provider Lens ® Research The ISG Provider Lens ® Quadrant research series is the only service provider evaluation of its kind to combine empirical, data-driven research and market analysis with the real-world experience and observations of ISG's global advisory team. Enterprises will find a wealth of detailed data and market analysis to help guide their selection of appropriate sourcing partners, while ISG advisors use the reports to validate their own market knowledge and make recommendations to ISG's enterprise clients. The research currently covers providers offering their services globally, across Europe, as well as in the U.S., Canada, Mexico, Brazil, the U.K., France, Benelux, Germany, Switzerland, the Nordics, Australia and Singapore/Malaysia, with additional markets to be added in the future. For more information about ISG Provider Lens ® research, please visit this webpage. About ISG ISG (Nasdaq: III) is a global AI-centered technology research and advisory firm. A trusted partner to more than 900 clients, including 75 of the world's top 100 enterprises, ISG is a long-time leader in technology and business services that is now at the forefront of leveraging AI to help organizations achieve operational excellence and faster growth. The firm, founded in 2006, is known for its proprietary market data, in-depth knowledge of provider ecosystems, and the expertise of its 1,600 professionals worldwide working together to help clients maximize the value of their technology investments.
Business Journals
3 hours ago
- Business Journals
GLP-1s: Life after FDA enforcement returns
Unless you've been living on another planet over the past few years, you have heard of and probably know several people that are taking glucagon-like peptide-1 drugs or GLP-1s. These revolutionary drugs, originally developed for type 2 diabetes, have become the pharmaceutical industry's most sought-after innovation thanks to their weight-loss benefits. Brand names include Ozempic® and Wegovy®, which are based on semaglutide and owned by Novo Nordisk, and Mounjaro® and Zepboud®, which are based on tirzepatide and owned by Eli Lilly. Their commercial trajectory is unparalleled with $52 billion in global sales in 2024, $64 billion predicted for 2025, and $130 billion per year expected by 2030. Humira, the best selling drug of all time won't come close to these as it has 'only' generated around $250 billion since 2003 and is expected to generate another $9-10 billion per year for the foreseeable future. However, the road to this commercial success has been one of the more interesting ones as it has brought up FDA, patent, national, and international issues. These issues began in March of 2022 for semaglutide GLP-1s and in December of 2022 for tirzepatide GLP-1s when the FDA listed each of them on the drug shortage list. Inclusion on the drug shortage list means that the FDA has determined that the demand for a specific drug exceeds its supply and that shortage has a significant impact on public health. During the time a drug is on the shortage list, the FDA does not generally institute any enforcement actions against compounders that are making copies. Once compounders were free to make compounded versions of GLP-1s, demand surged even higher as compounders began offering these drugs. Costs to consumers plummeted from $1000/month or more for the brand name drugs to $150/month or less for the compounded versions. Overnight, an entire cottage industry was born. However, this all came crashing to a halt when the FDA declared the shortage over, thereby ending its enforcement discretion. The FDA provided a phaseout period for the compounded drugs and their compounding facilities based the drug, semaglutide or tirzepatide, and the type of compounding pharmacy. The phaseout for all of the drugs and pharmacies ended on May 22, 2025. Thus, in order for compounders to continue offering these drugs, they must be presented with a valid patient-specific prescription to prepare the medications and the medications they compound must be tailored to that individual's specific needs that prevent them from taking the brand-name version. Novo Nordisk and Eli Lilly wasted no time notifying compounders that they must cease compounding these drugs. Eli Lilly filed suits against some of the larger compounding pharmacies, Empower Pharmacy and Strive Phramacy in April 2025. These suits were filed under the Lanham Act, based on the alleged illegal compounding of tirzepatide mixed with additives like vitamin B12 and glycine and thereby misleading customers into believing these products were FDA-approved. Compounders either continued to add or began adding these ingredients in order to fall under the exceptions for compounders based on the patient's specific needs. Novo Nordisk began working with Hims and Hers Health, Inc in April after the shortage for Wegovy® was declared over. This agreement was terminated in June 2025 when Novo Nordisk alleged that Hims and Hers was not complying with the law which prohibits mass sales of compounded drugs under the false guise of "personalization" and are disseminating deceptive marketing that put patient safety at risk. Novo Nordisk is also investigating additional compounders and telehealth providers for deceptive marketing based on this 'personalization' exception. With respect to the patent issues at play, Novo Nordisk has patents on semaglutide in the U.S. and most of the world that last until 2033 while Eli Lilly's tirzepatide U.S. and worldwide patents don't expire until 2036. However, generic versions of semaglutide are on the near term horizon. How you might ask? Well, Novo Nordisk failed to pay their patent maintenance fee in Canada in 2020. This means that the patent in Canada officially expired in 2020 but has been protected under Canadian laws governing data exclusivity which prevent generics from copying the drugs until January 4, 2026. Major generic-producing companies like Sandoz and Dr. Reddy's have already announced that they will be launching generic versions of semaglutide in 2026. The impact on consumers in Canada will be felt almost immediate. Additionally, consumers in the U.S. stand to benefit from the availability of generic semaglutide as the FDA generally turns a blind eye to individuals in the U.S. receiving their medications from Canada. Thus, the result of their failure to pay this maintenance fee will extend beyond Canada into semaglutide's largest commercial market. All in all, the market for GLP-1s has changed significantly since the FDA declared their shortages over. Most U.S. compounders have now ceased large-scale GLP 1 production. However, some continue to operate under state pharmacy boards or under legal protest, challenging the FDA's interpretation of "commercially available" in compounding laws. In a sense, they contend that the demand is still higher than Novo Nordisk and Eli Lilly can address. How this will play out legally remains to be seen. Sandberg Phoenix is a full-service law firm specializing in business, business litigation, health law, products liability, and intellectual property. Tracey joined Sandberg Phoenix as a shareholder in 2023, and is Practice Group Leader of the Intellectual Property practice group. With over 25 years of experience in intellectual property law, Tracey serves clients of all sizes across industries including biotechnology, agribusiness, food, health care and life sciences. He counsels clients on patent, trademark, and copyright acquisition, licensing, enforcement issues, due diligence, prosecution, litigation and other general business matters.
